中国学术期刊综合评价数据库统计源期刊
中国学术期刊影响因子统计源期刊
中国生物医学文献数据库(CBM)收录期刊

Most Accessed

  • Published in last 1 year
  • In last 2 years
  • In last 3 years
  • All

Please wait a minute...
  • Select all
    |
  • FAN Minghui1, XIE Jincheng1, WANG Lianghong1, ZHANG Xiling2, WANG Xinkang2
    Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 318-326. https://doi.org/10.13308/j.issn.2097-5716.2025.03.002
    Objective  To develop a transfer learning-based classification model for sleep apnea syndrome using electrocardiogram (ECG) data, increasing its classification accuracy and clinical applicability. Methods  Based on the Apnea-ECG and MIT-BIH polysomnographic databases, with respiratory signals as input, we applied a Butterworth low-pass filter for denoising, and constructed an original data set. To address the problem of insufficient respiratory signal data, a model training method based on a transfer learning approach was proposed: first, ECG signals with a large sample size were used for model pre-training, and then they were fine-tuning for respiratory signals, finally fulfilling binary classification or multi-class classification tasks. A cascade model combining residual network and bidirectional long short-term memory network was proposed, which performed better in capturing the timing features of signals and improving classification performance. Additionally, the performance of this model was made comparative analysis with those of various classic convolutional neural networks. Results  Through comparative experiments, it was found that employing transfer learning approach could accelerate model convergence and improve the model's overall performance. Validated on the test set, the proposed cascade model demonstrated a favorable performance in both binary classification and multi-class classification tasks, achieving an accuracy of 95.43% on the binary classification task and 91.26% on the multi-class classification task. Conclusion  This study offers novel insights into the design of disease classification models under small-sample conditions, and validates the effectiveness of transfer learning in sleep apnea syndrome classification, thereby demonstrating its potential clinical utility.
  • WANG Huixin, WU Yicheng, SU Yan'gang
    Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 313-318. https://doi.org/10.13308/j.issn.2097-5716.2025.03.001
    Objective  To investigate the correlation between ambulatory arterial stiffness index (AASI) and pulse pressure or blood pressure variability (BPV) in patients with obstructive sleep apnea hypopnea syndrome (OSAHS). Methods  A total of 205 patients specifically diagnosed with OSAHS were enrolled as research objects. They completed general data collection, and polysomnography and ambulatory blood pressure monitoring. Based on the classification of circadian blood pressure rhythm, the study population was divided into a dipper blood pressure group (n=92) and a nondipper blood pressure group (n=113). We compared the general clinical characteristics between the two groups as well as the correlation between AASI and ambulatory blood pressure parameters by using Pearson correlation analysis. Multiple linear regression analysis was applied to explore the relationship between AASI and pulse pressure or BPV. Results   The AASI of the non-dipper blood pressure group was significantly higher than that of the dipper blood pressure group (P<0.01). AASI was positively correlated with age, 24-hour mean systolic blood pressure and pulse pressure, while it was negatively correlated with 24-hour mean diastolic blood pressure, and the decline ratio of nocturnal systolic and diastolic blood pressure (all P<0.05). Pulse pressure was associated with AASI if BPV remained constant (P<0.05). Conclusion  The AASI of OSAHS patients demonstrates an association with pulse pressure and age. AASI may serve as a promising indicator reflecting arterial stiffness.
  • SU Guizhu, ZHUO Liqing
    Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 327-330. https://doi.org/10.13308/j.issn.2097-5716.2025.03.003
    Objective  To explore the association between obstructive sleep apnea syndrome (OSAS) and heart rate variability (HRV) or circadian rhythm of blood pressure in hypertensives. Methods  A total of 102 inpatients and outpatients with hypertension were selected in our study, and they were divided into hypertension with OSAS group (55 cases) and primary hypertension group (47 cases). This study enrolled 50 concurrent healthy subjects (all with organic diseases excluded, and without comorbidities of hypertension or OSAS) as a control group. We compared and analyzed the HRV time-domain indexes of SDANN and rMSSD, and HRV frequency-domain indexes of LF and HF, as well as apnea hypopnea index (AHI), nocturnal mean oxygen saturation level, daytime and nocturnal blood pressure levels, and changes of circadian blood pressure rhythm. Results  The nocturnal minimum saturation of arterial oxygen (SaO2) and nocturnal mean SaO2 of patients in the hypertension with OSAS group were both lower than those of patients in the primary hypertension group, while AHI was higher (all P<0.05). There were no statistically significant differences in the above sleep respiratory parameters between the primary hypertension group and the control group (all P>0.05). There were no statistically significant differences in the daytime and nocturnal blood pressure levels, and the incidence of non-dipper pattern between the primary hypertension group and the control group (all P>0.05). Comparisons of the aforementioned parameters between the hypertension with OSAS group and the control group all demonstrated statistically significant differences (all P<0.01). The hypertension with OSAS group exhibited a significantly higher prevalence of non-dipper circadian blood pressure rhythm compared to the other two groups (all P<0.05). Compared to the other two groups, the values of SDANN and LF of patients in the hypertension with OSAS group were higher, while the values of rMSSD and HF were lower (all P<0.05). There were no statistically significant differences in the LF, HF, SDANN and rMSSD values between the primary hypertension group and the control group (all P>0.05). Conclusion  Patients with OSAS demonstrate increased nocturnal blood pressure level, enhanced sympathetic nerve tension and decreased vagus nerve tension, as well as increased risk of cardiovascular and cerebrovascular diseases.
  • LIN Xiaohua, OUYANG Yu, CHENG Xiao, XIAO Jingwen, JIANG Yu, WEI Qinfei, ZHANG Yan
    Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 494-500. https://doi.org/10.13308/j.issn.2097-5716.2025.04.004
    Objective  To investigate the impact of long non-coding RNA ZFAS1 (lncZFAS1) on the initiation and progression of cardiomyocyte fibrosis. Methods  HL-1 mouse cardiac myocytes were induced by transforming growth factor-β (TGF-β) to establish a cardiomyocyte fibrosis model. LncZFAS1 overexpression vectors or small interfering RNA (siRNA) were transfected into the model. Protein levels of α-smooth muscle actin (α-SMA) and collagen Ⅰ were detected by western blotting; lncZFAS1 overexpression and interference fragments were transfected into the cardiomyocyte fibrotic model. The transcriptional level of lncZFAS1 was measured via real-time quantitative PCR. Cell proliferation viability was assessed using the CCK-8 assay, apoptosis rate was analyzed by flow cytometry, and LC3 autophagy puncta formation was examined using cellular immunofluorescence. Results  Compared with the control group, the TGF-β induction group showed significantly increased protein expression of α-SMA, collagen Ⅰ and LC3 B, significantly decreased p62 protein expression, elevated lncZFAS1 expression, enhanced cell viability and autophagy puncta formation, and reduced apoptosis rate (all P<0.05). After interfering with lncZFAS1 in the model, it showed a decrease in the expression level of lncZFAS1, a decrease in cell viability and the number of autophagy puncta, an increase of apoptosis rate and expression of p62 protein, and a decrease in the expression of LC3 B protein, all with statistically significant differences (all P<0.05). However, after overexpression of lncZFAS1, the opposite results were presented. Conclusion  LncZFAS1 promotes the initiation and progression of cardiomyocyte fibrosis by regulating cellular autophagy. Targeted inhibition of lncZFAS1 may provide a novel therapeutic strategy for delaying the progression of cardiovascular diseases.
  • YU Tao, ZHU Wenqing
    Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 469-476. https://doi.org/10.13308/j.issn.2097-5716.2025.04.001
    Artificial intelligence (AI) has significantly improved the screening and diagnostic efficiency of ventricular arrhythmia (VA) through electrocardiogram (ECG) interpretation and wearable device monitoring. In the treatment field, AI has made significant progress in assisting the localization of premature ventricular contraction origins and optimizing strategies for implantable cardioverter defibrillator therapies. AI models excel in predicting the risk of fatal VA, providing robust support for individualized prevention and treatment. This review further discusses challenges such as data quality, model interpretability, and clinical translation, as well as the role of multimodal data integration and interdisciplinary collaboration in advancing the precision medicine for VA. In the future, AI is expected to play a more pivotal role in remote healthcare, and individualized diagnosis and treatment, comprehensively enhancing diagnostic accuracy, treatment efficiency, and quality of life for VA patients.
  • DING Xiaojun1, ZHANG Youming2, GONG Junhui1, HAO Yingcai1, LIU Yusong1, SONG Yushu1, ZHU Hongtao1
    Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 501-507. https://doi.org/10.13308/j.issn.2097-5716.2025.04.005
    Objective  To explore the relationship between epicardial fat thickness (EFT), serum secreted frizzled-related protein 5 (SFRP5), wingless-type MMTV integration site family member 5a (Wnt5a), and in-stent restenosis (ISR) in patients with acute ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI). MethodsA total of 128 STEMI patients who had undergone emergency PCI were enrolled. After a 12-month follow-up, they were divided into a non-ISR group (80 cases) and an ISR group (48 cases) based on coronary angiography results. The general data between the two groups were compared, as well as the EFT before discharge and 1 month after surgery, and the serum levels of SFRP5 and Wnt5a measured before surgery and 1 month postoperatively. The differences in the levels of these indicators among patients with varying degrees of coronary artery lesions were also examined. Pearson correlation analysis was used to evaluate the association between EFT and serum levels of SFRP5 and Wnt5a 1 month after surgery. Multivariate Logistic regression analysis was applied to identify the risk factors of ISR in STEMI patients after PCI. ROC curve analysis was used to assess the predictive value of EFT, and serum SFRP5 and Wnt5a levels for ISR. ResultsThe EFT values of the ISR group before discharge and 1 month after surgery were both greater than those of the non-ISR group (all P<0.01). The serum SFRP5 level of the ISR group was lower than that of the non-ISR group 1 month after surgery, while the serum Wnt5a level was higher (all P<0.01). Compared to pre-operative levels, serum SFRP5 levels increased 1 month after surgery in the non-ISR group but decreased in the ISR group (both P<005). Serum Wnt5a levels showed a mild increase 1 month after surgery compared to pre-operative levels in the non-ISR group, but increased significantly in the ISR group (both P<0.05). The serum SFRP5 level 1 month after surgery was significantly lower in the three-vessel disease group than that in the single- or two-vessel disease groups (P<0.05). EFT 1 month after surgery showed a negative correlation with SFRP5 and a positive correlation with Wnt5a. Both univariate Logistic regression analysis and Logistic regression analysis adjusted for factors such as age and BMI demonstrated that EFT, and serum SFRP5 and Wnt5a levels 1 month after surgery were independent influencing factors for ISR. ROC curve analysis revealed that the combination of these three markers yielded an AUC value of 0.906, which was higher than that of detection with any single indicator. Conclusion  Increased EFT, decreased serum SFRP5, and elevated serum Wnt5a 1 month after surgery are closely related to ISR in STEMI patients after PCI. Early detection of these markers facilitates the prediction of ISR, and the combined detection offers superior predictive value.
  • WANG Yong, ZHAO Yonghui, WANG Zhen
    Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 508-513. https://doi.org/10.13308/j.issn.2097-5716.2025.04.006
    Objective  To investigate the application of dexmedetomidine via programmed intermittent epidural bolus (PIEB) for labor analgesia in hypertensive disorder of pregnancy (HDP) parturients, and its effect on umbilical artery flow and maternal-fetal outcomes. Methods  This study was a prospective, and double-blind clinical study. A hundred HDP parturients who had undergone labor analgesia were selected, and randomly divided into group A and B, each with 50 cases by random number table method. Group A received continuous epidural infusion, while group B received PIEB. Based on the visual analogue scale (VAS), the degree of pain before analgesia (T0), 1 h after analgesia (T1), 2 h after analgesia (T2), and at the time of complete cervical dilation (T3) were compared between the two groups of parturients. We simultaneously recorded the changes of umbilical artery flow at T0-T2 [umbilical artery resistance index (RI), pulsation index (PI) and the ratio of maximum systolic blood velocity to diastolic blood velocity (S/D)], maternal vital signs at T0 and T1 [heart rate (HR) and mean arterial pressure (MAP)], and the occurrence of adverse maternalfetal outcomes and adverse reactions in the two groups. ResultsComparison of VAS scores at different time points within each group showed statistically significant differences (all P<0.01). VAS scores at T1, T2 and T3 were all lower than that at T0(all P<0.05). VAS score of the group B at T2 was lower than that at T1(P<0.05). VAS score of the group B at T3 was lower than that at T2(P<0.05), while the VAS score of the group B at T2 or T3 were both lower than that of the group A (both P<0.01). There was no statistically significant difference in VAS score between the two groups at T0 and T1(P>0.05). Statistically significant differences were observed in RI, PI, and S/D values across different time points within both groups (all P<0.01). At T1 and T2, the RI, PI, and S/D ratio of fetuses in both groups all decreased compared to T0(all P<0.05). At T2, the RI, PI and S/D ratio of fetuses in both groups were all lower than those at T1(all P<0.05). There were no statistically significant differences in fetal RI, PI, and S/D ratio between the two groups at T0, T1 or T2(all P>0.05). At T1, HR and MAP in the two groups were both lower than those at T0(both P<0.05), while HR and MAP of the group B were both lower than those of the group A (both P<0.05). There were no statistically significant differences in the total incidences of adverse maternal-fetal outcomes or drug adverse reactions between the two groups (all P>0.05). Conclusion  Dexmedetomidine via PIEB could improve the effect of labor analgesia in HDP parturients, and maintain stability of fetal umbilical hemodynamics and maternal vital signs, with a high safety.
  • LIU Yu
    Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 477-450. https://doi.org/10.13308/j.issn.2097-5716.2025.04.002
    This article focuses on the application of artificial intelligence (AI) technology in the diagnosis and treatment of arrhythmias, and briefly introduces the latest relevant research findings from both domestic and international sources. It not only outlines the capability of AI in significantly improving the detection efficiency and accuracy of arrhythmia screening and diagnosis, but also emphasizes its value in the prediction of arrhythmia and the risk of its related complications, and guidance of its clinical treatment. Furthermore, this article summarizes the challenges faced by AI in arrhythmia management, including data quantity and quality issues, the “black box” effect in AI learning process, model generalization issues, ethical issues in technology, and the clinical acceptance of AI models. Finally, it looks forward to the prospect of AI technology deeply integrating with medicine, and comprehensive application in all aspects of arrhythmia diagnosis and treatment, so as to optimize medical resource allocation and medical service workflows, increase medical efficiency and quality, and improve patients’ prognoses.
  • BIE Hengjie, FU Yahong, JIA Enzhi, TAO Zhengxian
    Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 481-493. https://doi.org/10.13308/j.issn.2097-5716.2025.04.003
    Objective  To investigate the regulatory role and underlying mechanism of circular RNA circHECTD1, a potential diagnostic biomarker for coronary heart disease (CHD), in macrophage polarization. Methods  A lipopolysaccharide-induced M1 macrophage polarization model was used to simulate a low-grade inflammatory response process. Quantitative real-time PCR (qRT-PCR) was employed to detect the expression levels of circHECTD1 and N6-methyladenosine (m6A) regulatory factors. Western blotting was performed to measure the expression of M1 phenotype marker proteins and autophagyrelated proteins. Intracellular reactive oxygen species (ROS) levels were assessed by flow cytometry. Results  Silencing circHECTD1 significantly reduced the expression of M1 phenotype-related proteins and inflammatory cytokines, decreased ROS levels, and enhanced cellular autophagy. Disordered expression of multiple m6A regulatory factors was observed in both the cellular model and peripheral blood mononuclear cells (PBMCs) from CHD patients. Significant differences in the expression levels of multiple m6A methylation regulators were identified between CHD and control groups, suggesting their potential value in CHD diagnosis. Univariate and multivariate Logistic regression analysis revealed that the m6A regulators of METTL3, METTL14, ALKBH5, and YTHDC2 were significantly associated with CHD risk. Further analysis showed that the expression of METTL14 and ALKBH5 were significantly upregulated in advanced stages of atherosclerosis. The expression level of circHECTD1 significantly correlated with FTO, YTHDF3, ALKBH5, METTL3, METTL14, and YTHDF2. In vitro experiment results demonstrated that silencing METTL14 and ALKBH5 markedly downregulated circHECTD1 expression, indicating that METTL14 and ALKBH5 positively regulated circHECTD1 expression. Conclusion  Dysregulation of m6A regulatory factors may be closely associated with the occurrence and development of CHD, potentially mediated through the regulation of circHECTD1 expression and function.
  • CHEN Shangli1, 2, CHEN Xuan3, CHEN Ruojin4, QIN Tao5, WANG Zhenyan1, TANG Zhi6
    Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 331-337. https://doi.org/10.13308/j.issn.2097-5716.2025.03.004
    Objective  To investigate the association between homocysteine (Hcy) and the C677T gene polymorphism in its key metabolic enzyme, methylenetetrahydrofolate reductase (MTHFR), and the complications of hypertension, type 2 diabetes mellitus and atherosclerosis in patients with obstructive sleep apnea hypopnea syndrome (OSAHS). Methods  A total of 85 OSAHS patients and 77 non-OSAHS patients were enrolled. The genotypes, and levels of serum Hcy, fasting blood glucose and hemoglobin Alc of all subjects were detected, while cervical vascular ultrasound was performed simultaneously. Hcy≥10 μmol/L was defined as hyperhomocysteinemia (HHcy). The serum Hcy levels were compared among patients with different genotypes. The Hcy levels, MTHFR C677T gene polymorphism, and C/T allele frequencies were compared among an OSAHS with complications group, a pure OSAHS group, and a control group (without OSAHS or complications). Then, multivariate binary Logistic regression analysis was performed to identify independent risk factors for complications in OSAHS patients with confounding factors adjusted. Results  The Hcy levels in the patients with CC, CT and TT genotypes were 10.11 (9.15, 11.07), 10.86 (9.58, 11.10) and 15.81 (11.43, 50.76) μmol/L, respectively. Hcy level in the patients with TT genotype was significantly higher than that in the cases with CT or CC genotypes (both P<0.05). The Hcy levels of the OSAHS with complications group, the pure OSAHS group, and the control group were 11.16 (10.05, 13.80), 9.88 (9.31, 11.41), and 10.38 (9.29, 11.34) μmol/L, respectively. The Hcy level of the OSAHS with complications group was significantly higher than that of the pure OSAHS group (P<0.05). There were no statistically significant differences in gene polymorphism or C/T allele frequency among the three groups. After adjusting for confounding factors, it revealed that HHcy was an independent risk factor for concurrent complications in OSAHS patients, and the odds ratio (95% confidence interval) was 4.682 (1.261-17.380). Conclusion  The MTHFR C677T gene polymorphism affects serum Hcy level. HHcy is an independent risk factor for concurrent complications in OSAHS patients, however, neither the MTHFR C677T gene polymorphism nor the C/T allele frequency were associated with complications in OSAHS patients.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 310-310.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 156-156.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 312-312.
  • MAHEMUTI Zilalan, FAN Ping
    Practical Electrocardiology and Clinical Treatment. 2025, 34(5): 631-636. https://doi.org/10.13308/j.issn.2097-5716.2025.05.002
    Electrocardiogram (ECG) serves as a crucial tool for diagnosing cardiovascular diseases. With the rapid advancement of artificial intelligence (AI) technology, the application of AI in ECG analysis has gradually become a research hotspot. AI technology not only enables automated and accurate ECG interpretation, but also significantly improves the efficiency and accuracy of largescale cardiovascular disease screening in populations. This review summarizes the latest progress in AIassisted ECG analysis for cardiovascular system diseases, with a focus on its applications in arrhythmias, structural heart diseases, and acute cardiovascular events. Furthermore, it discusses development directions. As explainable AI technology evolves in the future, AIECG models are expected to be more widely adopted in clinical practice.
  • SHAO Meng'en, ZHANG Jingbin, BIAN Hengkai, SHI Yufei, SU Ruiying
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 167-170. https://doi.org/10.13308/j.issn.2097-5716.2025.02.003
    Objective  To study the diagnostic value of echocardiography and phonocardiography for coronary heart disease (CHD). Methods  A total of 102 patients suspected with CHD were selected, including 7 negative patients and 95 positive patients. Among the positive cases, there were 3 cases with the stenosis degree of arterial vessel's diameter less than 50% (group A), 36 cases with the stenosis degree of arterial vessel's diameter greater than or equal to 50% and less than 75% (group B), and 56 cases with the stenosis degree of arterial vessel's diameter greater than or equal to 75% (group C). Based on coronary angiography results as the gold standard, the positive rates of CHD and the detection rates of different degrees of coronary artery stenosis were compared between the two examination methods. Results  Coronary stenosis was detected in 7 patients (7.37%) by echocardiography; no coronary stenosis was detected in group A, one case (2.78%) was detected in group B, and 6 cases (10.71%) were detected in group C. Coronary stenosis was detected in 78 patients (82.11%) by phonocardiography including 2 patients (66.67%) in group A, 28 patients (77.78%) in group B, and 48 patients (85.71%) in group C. The difference in the positive rate of CHD was statistically significant between the two examination methods (P<0.05). In the diagnosis of CHD, the specificity, sensitivity and accuracy rate of echocardiography were 100%, 7.37% and 13.73%, respectively; the specificity, sensitivity and accuracy rate of phonocardiography were 14.23%, 82.11% and 77.45%, respectively. Conclusion  The diagnostic results of phonocardiogram based on the fourth heart sound are more in line with the diagnostic results of the gold standard. Therefore, phonocardiogram has a relatively high diagnostic value for CHD. Meanwhile, its overall diagnostic coincidence rate is also higher than that of echocardiography.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 311-311.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 155-155.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(4): 466-466.
  • LI Yanhong, HE Qian
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 176-180. https://doi.org/10.13308/j.issn.2097-5716.2025.02.005
    Objective  To explore interleukin-6 (IL-6) and neutrophils to lymphocytes ratio (NLR) combined with native T1 value in the prognosis evaluation of patients with viral myocarditis (VMC). Methods  A total of 156 patients with confirmed VMC were selected as research objects. After 12 months of follow-up, they were grouped into a poor prognosis group (40 cases) and a good prognosis group (116 cases) according to the follow-up results. The clinical data of the patients were collected, and Logistic regression analysis was used to investigate the influence of IL-6, NLR and native T1 value on the prognosis of VMC patients. ROC curve was utilized to evaluate the predictive efficiency of the above parameters for the prognosis of VMC patients. ResultsThe levels of IL-6, hs-cTn I and NT-proBNP, NLR, and native T1 value in the poor prognosis group were all significantly higher than those in the good prognosis group, and the differences were all statistically significant (all P<0.05). Binary Logistic regression analysis showed that IL-6, NLR and native T1 value were all independent influencing factors for the prognosis of VMC. ROC analysis demonstrated that the effect of the combination of IL-6 (regarding 12.895 pg/mL as the optimal cut-off value), NLR (regarding 3.495 as the optimal cut-off value) and native T1 value (regarding 1 122.0 ms as the optimal cut-off value) in predicting the prognosis of VMC patients was better than that of any single test, with a sensitivity of 87.5% and a specificity of 96.6%. Conclusion  The level of IL-6, NLR and native T1 value were significantly elevated in VMC patients with poor prognosis, and they could be served as auxiliary predictive indicators for the prognosis. The combined detection of the three indicators shows good predictive efficiency for poor prognosis of VMC.
  • SUN Xia, CUI Xinggang, ZHONG Wei, CHEN Guanghua, DAI Zhiyin, YUAN Wei, ZHANG Chaopu
    Practical Electrocardiology and Clinical Treatment. 2025, 34(5): 654-658. https://doi.org/10.13308/j.issn.2097-5716.2025.05.006
    Objective To analyze the therapeutic effect of low-flow oxygen inhalation in elderly patients with hypertension complicated by obstructive sleep apnea syndrome (OSAS). Methods A total of 175 elderly patients with hypertension and OSAS were selected as study subjects. All patients received conventional antihypertensive medication as recommended by guidelines. Those receiving continuous positive airway pressure (CPAP) therapy, low-flow oxygen inhalation therapy, and no corresponding intervention were assigned to a CPAP group (55 cases), a low-flow oxygen group (60 cases), and a control group (60 cases), respectively. Clinical data were collected, including body mass index, waist circumference, underlying diseases, laboratory test results and color Doppler echocardiography parameters, as well as systolic/diastolic blood pressure, Epworth sleepiness scale (ESS) scores, nocturnal minimum saturation of peripheral oxygen (SpO2), and apnea hypopnea index (AHI) before and after intervention (3 months of treatment). ResultsBlood pressure control and respiratory parameters in the low-flow oxygen group both improved significantly after oxygen inhalation (both P<0.05). After 3 months of follow-up, the nocturnal minimum SpO2 in both the low-flow oxygen and CPAP groups increased significantly compared with pre-intervention levels (both P<0.01). There was statistically significant difference in nocturnal minimum SpO2 after intervention among the three groups (P<0.01). After pharmacotherapy or intervention, systolic and diastolic blood pressures both decreased significantly in all the three groups compared with pre-intervention levels (all P<0.05), and post-intervention differences in systolic and diastolic blood pressures among the three groups were statistically significant (all P<0.05). Compared with baseline, both the low-flow oxygen group and the CPAP group demonstrated significant reduction in ESS score and AHI after the intervention (both P<0.05). Conclusion Low-flow oxygen inhalation therapy in elderly patients with hypertension and OSAS could partially improve sleep respiratory parameters, increase nocturnal SpO2, and help to increase the compliance rate of blood pressure control, reduce the use of antihypertensive medication and alleviate economic burden.
  • REN Zhiyi, CHEN Zhen
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 157-161. https://doi.org/10.13308/j.issn.2097-5716.2025.02.001
    Objective  To investigate the long-term prognosis of renal dysfunction patients with fragmented QRS complex (fQRS). Methods  A total of 181 inpatients specifically diagnosed with renal dysfunction were selected as research objects. We collected their general information, laboratory test results, routine ECGs, readmissions, and mortality. They were divided into positive fQRS group (n=96) and negative fQRS group (n=85) based on the presence or absence of fQRS in the ECG. The cohort study method was used to compare the occurrence of readmission and death events between the two groups. ResultsThe readmission time of patients in the positive fQRS group was earlier than that in the negative fQRS group, and the difference was statistically significant (HR=2.486, P<0.01). The index of fQRS was an independent predictor of readmission in patients with renal dysfunction. There was no statistically significant difference in the time to death between the two groups (P=0.312). The estimated glomerular filtration rate and NT-proBNP were associated with the time to death (P=0.025 and 0.020, respectively). Conclusion  Renal dysfunction patients with fQRS are more likely to be readmitted. Patients with poorer renal function and elevated NT-proBNP levels demonstrate both higher mortality rates and accelerated time to death. Early screening of fQRS and related risk factors help to assess the prognosis of these patients.
  • ZHAO Bo1, ZHANG Mengyao1, FENG Zhenqin1, YANG Xinyu1, YU Zongliang1, TANG Fengyan2
    Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 342-347. https://doi.org/10.13308/j.issn.2097-5716.2025.03.006
    Objective  By comparing the characteristics of chest lead electrocardiogram (ECG) indicators related to premature ventricular contraction (PVC), to explore the ECG indicators that can identify the origin point of outflow tract PVC more accurately. Methods  Seventy-eight patients with outflow tract PVC who had received successful radiofrequency catheter ablation were retrospectively analyzed. Among them, 52 cases of PVC were originated from the right ventricular outflow tract (RVOT), while 26 cases were originated from the left ventricular outflow tract (LVOT). The V2 transition index, SV2/RV3 index, RV1 wave duration index (RdV1/QRSdV1) and RV1/SV1 amplitude index were measured respectively. Each parameter and its diagnostic efficacy in differentiating outflow tract PVC were compared, and analyzed between the two groups. Results  There were no statistically significant differences in clinical features including age, sex, body mass index, smoking history, drinking history, complicated hypertension, complicated diabetes, cardiac structural and functional parameters, preoperative ventricular arrhythmia burden by 24-hour ambulatory electrocardiography (AECG), and preoperative anti-arrhythmic drug types between the two groups (all P>0.05). V2 transition index, SV2/RV3 index, RdV1/QRSdV1 and RV1/SV1 amplitude index were all significantly different between the two groups (all P<0.01). ROC analysis and decision curve analysis (DCA) were used to explore the diagnostic performance of each parameter in distinguishing the origin of outflow tract PVC. The AUC value of V2 transition index was 0.837, its optimal cut-off value was 0.76, and the sensitivity, specificity and accuracy rate were separately 0.718, 1.000 and 0.780. The AUC value of SV2/RV3 index was 0.859, its optimal cut-off value was 3.48, and the sensitivity, specificity and optimal accuracy rate were separately 0.718, 1.000 and 0.780. The AUC value of RdV1/QRSdV1 was 0.741, its optimal cut-off value was 0.35, and the sensitivity, specificity and accuracy rate were separately 0.487, 1.000 and 0.600. The AUC value of RV1/SV1 amplitude index was 0.836, its optimal cut-off value was 0.34, and the sensitivity, specificity and accuracy rate were separately 0.692, 0.909 and 0.740. V2 transitional index and SV2/RV3 index had higher diagnostic predictive value. DCA results showed that SV2/RV3 index demonstrated the highest net benefit. Based on age, sex, body mass index, smoking and drinking history, hypertension, diabetes, cardiac structural and functional parameters, preoperative ventricular arrhythmia burden, and the use of preoperative anti-arrhythmic drugs, we constructed a basic model. After adding V2 transition index to it, the differentiation performance of the model was significantly improved (C-index was 0.924, 95% confidence interval: 0.851-0.996, P=0.003); after adding SV2/RV3 index, its differentiation performance was further improved (C-index was 0.953, 95% confidence interval: 0.905-1.000, P<0.001). Conclusion  V2 transition index and SV2/RV3 index have relatively high differentiation value in locating the origin of outflow tract PVC, especially SV2/RV3 index demonstrating very high clinical utility value for PVC migrating in lead V2-V3.
  • Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 154-154.
  • ABUDUWAILI Aikeda, WU Lijun
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 267-271. https://doi.org/10.13308/j.issn.2097-5716.2025.02.022
    Systemic lupus erythematosus (SLE) is an autoimmune disease that produces a large number of pathogenic autoantibodies and immune complexes, damaging multiple tissues and organs. With the update of the classification criteria proposed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) in 2019, as well as the guidelines for the diagnosis and treatment of SLE, our understandings of SLE, and the level of its diagnosis and treatment have been significantly improved. However, due to the incompletely elucidated pathogenesis of the disease, there is still a lack of targeted intervention measures at present, and the prognosis is not optimistic. In the study of the pathogenesis of SLE, the imbalance of Th17/Treg cells has drawn significant attention. Probing into the key molecules related to their equilibrium is expected to open up a new path for the precise treatment of SLE.
  • JU Aiping, MENG Xiangrong, QIN Yanling, GU Yuying
    Practical Electrocardiology and Clinical Treatment. 2025, 34(5): 665-671. https://doi.org/10.13308/j.issn.2097-5716.2025.05.008
    Objective To explore the clinical performance of non-invasive prenatal testing (NIPT) in screening for fetal chromosomal copy number variations (CNVs). Methods In this retrospective cohort study, 196 high-risk NIPT samples were analyzed. The results of chromosomal karyotyping analysis or chromosomal microarray analysis (CMA) were compared. The positive rate and positive predictive value (PPV) of fetal CNVs, and other clinical data were screened by NIPT, so as to assess the detection value of NIPT for fetal CNVs. Results A total of 20 378 NIPT samples were tested. Among the 196 high-risk samples, 54 were CNVs, with a screening positive rate of 0.265%. Forty-six pregnant women underwent interventional prenatal diagnosis, among whom there were 21 cases confirmed with CNVs including 13 cases with pathogenic variations, 3 cases with likely pathogenic variations, and 5 cases with variations of unknown significance. The PPV of NIPT for screening CNVs was 45.65%. Seventeen cases of microdeletion CNVs and 36 cases of microduplication CNVs were screened out by NIPT, and 1 case was microdeletion combined with microduplication CNVs, accounting for 31.48% (17/54), 66.67% (36/54), and 1.85% (1/54), respectively. The corresponding PPVs were 64.29%, 35.48% and 100.00%, respectively. Statistical analysis showed that there were no statistically significant differences in the positive rate and PPV of NIPT for screening microdeletion CNVs and microduplication CNVs (all P>0.05). Conclusion NIPT demonstrates relatively high positive rate and PPV for screening fetal CNVs. Interventional prenatal diagnosis should be recommended for those with high-risk of CNVs by NIPT. NIPT combined with chromosomal karyotyping analysis and CMA could provide precise genetic counseling and guidance for clinical practice.
  • WU Jianmin1, XIA Yu2, HU Zhicheng2, WU Lingmin2, DING Ligang2, YAO Yan2
    Practical Electrocardiology and Clinical Treatment. 2025, 34(3): 338-341. https://doi.org/10.13308/j.issn.2097-5716.2025.03.005
    Objective  To study the clinical efficacy and safety of radiofrequency catheter ablation for atrial fibrillation (AF) by domestic minimally invasive Columbus  system. Methods  A total of 26 patients with AF who had undergone radiofrequency catheter ablation with Columbus  system and its supporting catheter were successively selected. The immediate success rate of surgery, intraoperative related parameters and surgery-related complications were recorded, while the recurrence of AF and the occurrence of adverse events were observed during follow-up. Results  The enrolled 26 patients were all paroxysmal AF. Pulmonary vein isolation was successfully achieved during operation, and there were no complications related to radiofrequency catheter ablation during perioperative period. During a mean follow-up of (5.92±1.94) months, AF recurred in 5 of 26 patients (19.23%). No serious adverse events such as embolism, bleeding, atrial esophageal fistula, or death occurred during the follow-up. Conclusion  Radiofrequency catheter ablation for AF by using domestic minimally invasive Columbus system is clinically feasible, with satisfactory short-term efficacy and safety.
  • MAO Weisheng, MAIMAITI Aerzuguli, FENG Yan
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 282-285. https://doi.org/10.13308/j.issn.2097-5716.2025.02.025
    Resting heart rate is an index reflecting the balance of cardiac autonomic nervous system, and it is also a risk factor leading to the occurrence of cardiovascular diseases and the increase of all-cause mortality. Resting heart rate as a simple and easy-to-measure physiological index has attracted more and more attention in the field of cardiovascular diseases in recent years. This paper reviews the research progress of the correlation between resting heart rate and cardiovascular diseases from different angles, including its influence on common cardiovascular diseases such as coronary heart disease, hypertension, heart failure and atrial fibrillation, as well as the control of resting heart rate.
  • WU Minghai, TANG Liling, CHEN Rui
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 162-166. https://doi.org/10.13308/j.issn.2097-5716.2025.02.002
    Objective  To investigate the effect of intra-aortic balloon pumping (IABP) combined with percutaneous coronary intervention (PCI) in the treatment of cardiogenic shock after acute myocardial infarction. Methods  Sixty patients with cardiogenic shock after acute myocardial infarction were selected. They were divided into two groups by the random number table method. Patients undergoing PCI treatment were enrolled in the PCI group, while patients receiving a combined therapy of PCI and IABP were assigned to the combination treatment group, with 30 cases in each group. We compared the changes in vital signs, cardiac function, and levels of inflammatory factors and myocardial injury markers before and after treatment, as well as the incidence of adverse cardiovascular events after surgery between the two groups. Results  After treatment, the mean arterial pressure in the combination treatment group was significantly higher than that in the PCI group [(104.06±9.79) mmHg vs. (91.27±8.84) mmHg, P<0.01]; the heart rate was significantly lower than that of the PCI group [(85.37±8.13) times/min vs. (94.72±8.94) times/min,P<0.01]. The peak IL-6 level of patients in the combination treatment group was advanced to 24 hours after surgery, while the combination treatment group exhibited a significantly smaller magnitude of TNF-α elevation compared with the PCI group (P<0.05). In the combination treatment group, the LVEF [ (45.27±4.35)%], cardiac output [ (5.52±0.77) L/min], and stroke volume [(78.89±7.75) mL] were all significantly higher than those in the PCI group [values of the above indexes were (40.84±3.81)%, (5.01±0.64) L/min, and (71.28±7.03) mL, respectively], while the left ventricular end-diastolic diameter was significantly smaller than that in the PCI group [(50.09±4.87) mm vs. (55.27±5.36) mm, P<0.01]. After treatment, the levels of N-terminal B-type natriuretic peptide (NT-proBNP), cardiac troponin and creatine kinase isoenzymes, and the incidence of adverse cardiovascular events in the combination treatment group were all significantly lower than those in the PCI group (all P<0.05). Conclusion  The combination of IABP and PCI for treating cardiogenic shock after acute myocardial infarction could significantly improve cardiac function compared with PCI therapy alone, which may be associated with alleviating the inflammatory response in the acute phase of myocardial infarction.
  • DU Yanli, DONG Suying, SHANG Yi, WANG Qinghao
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 171-175. https://doi.org/10.13308/j.issn.2097-5716.2025.02.004
    Objective  To observe the efficacy of breviscapine combined with levocarnitine in the treatment of patients with acute viral myocarditis (AVM), and analyze its impact on cardiac function and myocardial injury. Methods  Clinical data of 96 patients with AVM were retrospectively analyzed. These patients were divided into a levocarnitine group and a combination group according to the treatment plan, with 48 cases in each group. In addition to conventional therapy received by patients in both groups, the levocarnitine group received levocarnitine treatment, while the combination group received intravenous infusion therapy with breviscapine combined with levocarnitine. Both groups received continuous medication administration for 14 days. The efficacy and adverse reactions between the two groups were compared, as well as cardiac function indexes [LVEF, stroke volume (SV) and cardiac output (CO)], myocardial injury markers [cTn I, creatine kinase MB(CK-MB), lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and creatine kinase], inflammatory factors, and oxidative stress indicator levels before and after treatment. ResultsThe total effective rate of the combination group was higher than that of the levocarnitine group (91.67% vs. 70.83%, P<0.05). Compared with the levocarnitine group, the LVEF, SV and CO in the combination group were increased after treatment; serum cTn I, CK-MB, LDH, AST, creatine kinase, interleukin-6 and tumor necrosis factor-α (TNF-α) levels in the combination group after treatment were reduced, while the level of interleukin-4 was increased (all P<0.05). Compared with the levocarnitine group, serum superoxide dismutase (SOD) level in the combination group increased, while the advanced oxidation protein products (AOPP) and malondialdehyde levels reduced after treatment (all P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion  Breviscapine combined with levocarnitine could significantly improve the therapeutic effect on AVM patients, significantly ameliorate cardiac function, which may be related to the inhibition of inflammation-oxidative stress response, and has good safety.
  • CHAO Shengyan, CHEN Jieru, XIE Zhifei, HAN Rubing
    Practical Electrocardiology and Clinical Treatment. 2025, 34(2): 188-193. https://doi.org/10.13308/j.issn.2097-5716.2025.02.007
    Objective  To observe the changes in vertebral artery hemodynamic parameters by ultrasonic examination and serum calcitonin gene-related peptide (CGRP) level in patients with cervical vertigo, and to explore their assessment value for the therapeutic effect on cervical vertigo. Methods  A retrospective analysis was conducted on 108 patients with cervical vertigo (designated as a study group), while 36 healthy volunteers were selected during the same period as a control group. The vertebral artery hemodynamic parameters [systolic maximum blood flow velocity (Vmax) of the left vertebral artery (LVA), right vertebral artery (RVA), and basilar artery (BA)], and serum CGRP level were compared between the two groups. The LVA-Vmax, RVA-Vmax, BA-Vmax, and serum CGRP level in patients with different severities of vertigo were compared in the study group. The study group received routine treatment, and was divided into an effective subgroup with 74 cases and an ineffective subgroup with 34 cases based on the therapeutic effect after one month of treatment. The clinical data, and LVA-Vmax, RVA-Vmax, BA-Vmax and serum CGRP level before and after treatment were compared between the two subgroups. The influencing factors of efficacy were analyzed; the values of LVA-Vmax, RVA -Vmax, BA-Vmax and serum CGRP level in assessing the treatment efficacy were explored. ResultsThe LVA-Vmax, RVA-Vmax, BA-Vmax, and serum CGRP level in the study group were all lower than those in the control group (all P<0.01). The levels of LVA-Vmax, RVA-Vmax, BA-Vmax, and serum CGRP in the study group were ranked in ascending order as follows: patients with severe vertigo < those with moderate vertigo < those with mild vertigo (all P<0.05). After one month of treatment, the LVA-Vmax, RVA-Vmax, BA-Vmax, and serum CGRP level in the ineffective subgroup were all lower than those in the effective subgroup (all P<0.01). Multivariate Logistic regression analysis showed that age and disease duration were risk factors for treatment efficacy, while LVA-Vmax, RVA-Vmax, BA-Vmax, and serum CGRP level were protective factors for treatment efficacy (all P<0.05). After one month of treatment, the AUC value of the combined LVA-Vmax, RVA-Vmax, BA-Vmax, and serum CGRP level for assessing treatment efficacy was greater than that of any individual indicator (all P<0.01). Conclusion  Patients with cervical vertigo exhibit reduced ultrasonic examination parameters including LVA-Vmax, RVA-Vmax and BA-Vmax, and serum CGRP level, which are associated with the severity of vertigo and treatment efficacy. Combined detection of these parameter levels offers certain assessment value for treatment efficacy.